Your fact-checks

Your fact-checks will appear here

factually
Support us
  • Home
  • Politics
  • Business
  • Society
  • Technology
  • Health
  • Science
  • Entertainment
Index/Topics/Prostate Cancer Guidelines

Prostate Cancer Guidelines

Guidelines for prostate cancer treatment and management from NCCN, AUA, and EAU

Fact-Checks

3 results
Jan 12, 2026
Most Viewed

What are guideline differences between NCCN, AUA, and EAU on post‑prostatectomy PSA surveillance and why?

Three major prostate‑cancer guideline bodies—NCCN, AUA, and EAU—agree on the central role of serial PSA after radical prostatectomy but diverge on measurement sensitivity, timing of intervention, imag...

Jan 22, 2026

How should management (staging, systemic therapy, trials) change for patients with high‑grade prostate cancer and very low PSA?

(Grade Group 4–5 or Gleason ≥8) with a deceptively low serum PSA should trigger more aggressive staging and consideration of treatment intensification rather than reassurance; modern imaging (includin...

Jan 16, 2026

How do nomograms combine Gleason score, PSA/PSADT, and margin status to estimate individual metastasis risk after prostatectomy?

Nomograms are multivariable statistical tools that combine pathological and biochemical features—most commonly Gleason score, PSA level or PSA doubling time (PSADT), and surgical margin status—to gene...

About
Blog
Contact
FAQ
Terms & ConditionsTerms
Privacy PolicyPrivacy
Manage data